REVOLUTION Medicines Raises $56 Million Series B Financing at $1.50 per share Portfolio News / By admin April 24 2018
eFFECTOR Presents Data on the Discovery and Structure of eFT226, a Novel Inhibitor of eIF4A, at the AACR 2018 Annual Meeting Portfolio News / By admin April 16, 2018
Constellation Pharmaceuticals Announces $100 Million Financing at $1.00 per share Portfolio News / By admin April 9, 2018
Surrozen Strengthens Leadership Team with Addition of Craig Parker as New CEO and Hans Clevers as Scientific Co-founder Portfolio News / By admin April 4, 2018
